• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Cibus Inc.

    4/10/25 4:45:00 PM ET
    $CBUS
    Agricultural Chemicals
    Industrials
    Get the next $CBUS alert in real time by email
    DEFA14A 1 a2025defa14anoticeofinterna.htm DEFA14A a2025defa14anoticeofintern.htm

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ________________________
    SCHEDULE 14A
    PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
    SECURITIES EXCHANGE ACT OF 1934
    ________________________
    Filed by the Registrant x
    Filed by a Party other than the Registrant o
    Check the appropriate box:
    oPreliminary Proxy Statement
    oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    oDefinitive Proxy Statement
    xDefinitive Additional Materials
    oSoliciting Material Pursuant to §240.14a-12
    CIBUS, INC.
    (Name of Registrant as Specified in its Charter)
    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
    Payment of Filing Fee (Check all boxes that apply):
    xNo fee required.
    oFee paid previously with preliminary materials.
    oFee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     
    Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V69290-P27844 BROADRIDGE CORPORATE ISSUER SOLUTIONS C/O CIBUS, INC. P.O. BOX 1342 BRENTWOOD, NY 11717 CIBUS, INC. 2025 Annual Meeting Vote by May 21, 2025 11:59 PM PT You invested in CIBUS, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on May 22, 2025. Get informed before you vote View the Notice and Proxy Statement, Annual Report and Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 8, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Vote Virtually at the Meeting* May 22, 2025 10:00 AM PT Virtually at: www.virtualshareholdermeeting.com/CBUS2025


     
    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V69291-P27844 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of Directors: To elect seven directors until the next annual meeting of stockholders and until their successors have been elected and qualified. Nominees: 1a. Rory Riggs For 1b. Peter Beetham For 1c. Mark Finn For 1d. Jean-Pierre Lehmann For 1e. August Moretti For 1f. Gerhard Prante For 1g. Keith Walker For 2. To approve, on an advisory basis, the compensation of the company’s Named Executive Officers. For 3. Ratification of the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2025. For 4. To approve the adoption of the Cibus, Inc. 2025 Employee Stock Purchase Plan. For 5. To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of up to 9,040,000 shares of Class A common stock issuable upon the exercise of outstanding common warrants issued pursuant to those certain Securities Purchase Agreements, each dated January 21, 2025, by and among the Company and the purchasers party thereto. For 6. To approve, in accordance with Nasdaq Listing Rule 5635(c), the repricing of certain existing warrants of the Company held by Rory Riggs. For 7. To approve, in accordance with Nasdaq Listing Rule 5635(b), the issuance of shares of Class A common stock upon the potential future exercise of outstanding warrants held by Rory Riggs that would be deemed to be a “change of control” of the Company within the meaning of Listing Rule 5635(b). For NOTE: Such other business as may properly come before the meeting or any adjournment thereof.


     
     
    Get the next $CBUS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CBUS

    DatePrice TargetRatingAnalyst
    7/29/2024$25.00Buy
    Alliance Global Partners
    7/19/2024$22.00Buy
    Canaccord Genuity
    10/9/2023$25.00Buy
    H.C. Wainwright
    7/19/2023$30.00Buy
    Canaccord Genuity
    More analyst ratings

    $CBUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alliance Global Partners initiated coverage on Cibus Global with a new price target

      Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

      7/29/24 7:49:52 AM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • Canaccord Genuity resumed coverage on Cibus Global with a new price target

      Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00

      7/19/24 8:34:00 AM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • H.C. Wainwright initiated coverage on Cibus Global with a new price target

      H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00

      10/9/23 8:32:05 AM ET
      $CBUS
      Agricultural Chemicals
      Industrials

    $CBUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Research Sauer Noel was granted 11,750 shares, increasing direct ownership by 13% to 105,480 units (SEC Form 4)

      4 - Cibus, Inc. (0001705843) (Issuer)

      3/28/25 4:54:46 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • New insider Sauer Noel claimed ownership of 93,730 shares (SEC Form 3)

      3 - Cibus, Inc. (0001705843) (Issuer)

      3/28/25 4:50:18 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • CLO, Gen Csl & Secy Stokes Jason was granted 28,250 shares, increasing direct ownership by 28% to 127,669 units (SEC Form 4)

      4 - Cibus, Inc. (0001705843) (Issuer)

      3/28/25 4:38:32 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials

    $CBUS
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cibus Inc.

      10-Q - Cibus, Inc. (0001705843) (Filer)

      5/8/25 4:35:08 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • Cibus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Cibus, Inc. (0001705843) (Filer)

      5/8/25 4:19:03 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • SEC Form DEFA14A filed by Cibus Inc.

      DEFA14A - Cibus, Inc. (0001705843) (Filer)

      4/10/25 4:45:00 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials

    $CBUS
    Leadership Updates

    Live Leadership Updates

    See more

    $CBUS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

      EMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the appointment of Simon Harnest, MSc, BSc, as Chief Financial Officer. This key addition comes at a pivotal moment for Totus as the company prepares to advance its clinical-stage program following encouraging results from its Phase 1 study of TOS-358, a covalent PI3Kα inhibitor. "The addition of Simon, with over 15 years' experience in private capital markets strategy and IPO processes, comes at the right time for Totus as we advance our clinical-stage and discovery programs," said

      1/28/25 8:00:00 AM ET
      $CBUS
      $CLLS
      $MGX
      $CLXT
      Agricultural Chemicals
      Industrials
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Jim Collins to Join Cibus Board of Directors

      Cibus Announces Election of New Board Member, Deepening Strategic Leadership and Experience SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a global leader in Gene Editing in agriculture and the development of Productivity Traits in plants that directly impact farming productivity and profitability announced that its Board of Directors has elected Jim Collins, former CEO of Corteva, to the Board. "Jim brings to Cibus immense knowledge and strategic vision on the direction of the future role and use of Gene Editing in agriculture," said Mark Finn, Chair of the Audit Committee. "Jim's experience leading one of the largest agricultural and seed companies will gi

      9/18/23 5:23:58 PM ET
      $ADM
      $CBUS
      Packaged Foods
      Consumer Staples
      Agricultural Chemicals
      Industrials
    • Steve Berreth Appointed as General Counsel and Corporate Secretary

      SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, announced today the appointment of Steve Berreth as General Counsel and Corporate Secretary for the corporation. Mr. Berreth was previously Vice President, General Counsel and Secretary for Syngenta Crop Protection LLC, the North American Subsidiary of Syngenta AG, one of the world's largest biotechnology agribusinesses and one of the largest crop protection chemical and seed businesses in the world. He was a member of the Syngenta global legal and compliance leadership teams and led the North American le

      8/3/23 12:30:00 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025

      Rice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with customer germplasm integration underway across multiple markets Positive regulatory decision for Cibus' Rice traits HT1 and HT3 in Ecuador; the Ministry of Agriculture and Livestock in Ecuador determined that the Company's HT1 and HT3 Rice traits are equivalent to those developed through conventional breeding Disease resistance program advances with positive Sclerotinia data for multiple modes of action against Sclerotinia in Canola; Cibus' time bound and predictable RTDS tech

      5/8/25 4:05:00 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding

      SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that the Ministry of Agriculture and Livestock in Ecuador has determined that Rice cultivars containing Cibus' herbicide tolerance Rice traits (HT1 and HT3) are equivalent to those developed through conventional breeding and subject to the same regulations as conventional seed in accordance with the provisions of the Organic Law of Agrobiodiversity, Seeds and Promotion of Sustainable Agriculture and its Regulations. The Rice trait products reviewed were developed utilizing Cibus' Rapi

      5/7/25 7:00:00 AM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call

      SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2025 financial results on Thursday, May 8, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2025 Results Conference Call Event Date: Thursday, May 8, 2025Time: 4:30 p.m. ETParticipant Numbers: +1-833-316-1983 (U.S.), +1-785-838-9310 (International)The c

      4/25/25 7:00:00 AM ET
      $CBUS
      Agricultural Chemicals
      Industrials

    $CBUS
    Financials

    Live finance-specific insights

    See more
    • Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025

      Rice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with customer germplasm integration underway across multiple markets Positive regulatory decision for Cibus' Rice traits HT1 and HT3 in Ecuador; the Ministry of Agriculture and Livestock in Ecuador determined that the Company's HT1 and HT3 Rice traits are equivalent to those developed through conventional breeding Disease resistance program advances with positive Sclerotinia data for multiple modes of action against Sclerotinia in Canola; Cibus' time bound and predictable RTDS tech

      5/8/25 4:05:00 PM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call

      SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2025 financial results on Thursday, May 8, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2025 Results Conference Call Event Date: Thursday, May 8, 2025Time: 4:30 p.m. ETParticipant Numbers: +1-833-316-1983 (U.S.), +1-785-838-9310 (International)The c

      4/25/25 7:00:00 AM ET
      $CBUS
      Agricultural Chemicals
      Industrials
    • Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call

      SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2024 financial results on Thursday, March 20, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Fourth Quarter 2024 Results Conference Call Event Date: Thursday, March 20, 2025         Time: 4:30 p.m. ET         Participant Numbers: +1-877-300-8521 (U.S.), +1-412-317

      3/11/25 7:00:00 AM ET
      $CBUS
      Agricultural Chemicals
      Industrials